Lights, Camera, Intestines!
Scientists in Germany have developed a more patient-friendly approach to inner-stomach imaging, using magnets to guide tiny swallowable cameras in patients with stomach cancer.
Leukemia: Finding the Cause of the Cause
Researchers at Université du Québec à Montréal have identified a gene that may improve the diagnosis of B-cell acute lymphocytic leukemia, the most prevalent leukemia in children younger than 20 years of age.
Dying of Embarrassment
Although skin cancer is the most frequently diagnosed cancer in the United States, obstacles such as patient embarrassment prevent physicians from conducting full-body examinations.
False Alarms and Unnecessary Upsets
Patients with false-positive breast cancer mammograms report serious anxiety and a reduced quality of life for at least one year, according to new research from the Netherlands.
Brain Cancer Research Goes Viral
An enzyme known as chondroitinase might help oncolytic viruses (cancer-fighting viruses) more effectively destroy cancer cells in brain tumors by clearing out protein molecules that deter the virus’s mission.
Racial Disparities Among Colorectal-Cancer Screening
Minorities are much less likely to undergo colonoscopies than caucasians, according to a new study form the University of California at David Cancer Center.
HPV's Death-Defying Devices
Scientists have unraveled the two deadly weapons that make the human papillomavirus (HPV) able to lie dormant in the body for years, leading to chronic infection and even cancer.
The Dangers of Leaving the Light On
Keeping the lights on before going to sleep may have a negative influence on your health, according to a study to be published in the Journal of Clinical Endocrinology & Metabolism .
The Little Gene that Could
The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.
The ABCs About PSAs
Researchers at Duke Cancer Institute believe they have pinpointed why PSA (prostate-specific antigen) levels reflect cancer progression.